Companies · Healthtech

Reliance Health Inc.Winter 2017Active

AUSTIN · LA, Nigeria; Austin, TX, USA · Healthtech · refined from filed group “Other Technology · founded 2016 · https://www.getreliancehealth.com

Diligence memoA one-page analyst read on Reliance Health Inc. — recommendation, valuation, rhythm, risks.
$48.3M
Total raised · real
2
Rounds
1.0×
Latest step-up
Top 11%
Sector rank · raised
Series C
Latest stage · inferred · Tue Jan 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Reliance Health Inc. looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 1.37× the median modeled value of Series C Healthtech companies in 2022–2024 (39 peers) — value vs value, same stage and era.
  • Within the normal band (137% of peer median) for its niche.
Dormant
  • Last raise 4.4 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Healthtech

Reliance Health Inc. is one of 2138 Healthtech companies tracked from AUSTIN, LA, Nigeria; Austin, TX, USA, on record since 2016. By capital raised it ranks among the largest (ahead of 90% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

AI analyst read est. — model-extracted from this company's public description, not a verified fact. 30%

operates a technology-led product inferred from public copy

Grounded in: “You are a venture analyst

We make healthcare in emerging markets affordable and accessible

Reliance Health uses technology to make quality healthcare delightful, affordable and accessible in emerging markets. Through an integrated approach that includes affordable health insurance, telemedicine and a combination of partner and proprietary healthcare facilities, Reliance Health offers innovative healthcare solutions that meet the needs of emerging markets including Nigeria, Egypt and growing

Digital HealthHealth InsuranceHealth TechHealthcarehealthtechinsurance
Find Reliance Health Inc. online

As reported in public records reported — not modeled.

NG
Jurisdiction
Rule 506(b)
Reg D exemption
9
Investors (latest)
2022-01-25
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$250M$500M$750M$1.0BSeries A · 2020-03-11 Raised $8.3M (real) Modeled valuation $187M (est)$8.3M$187MSeries A2020Series C · 2022-01-25 Raised $40M (real) Modeled valuation $664M (est)$40M$664MSeries C2022Series C · 2022-02-07 Raised $40M (real) Modeled valuation $657M (est)$40M$657MSeries C2022+$40M+$40MCumulative $88M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$8.3M · 2020
Series C$40.0M · 2022no Series B on file
Series C extension$40.0M · 2022

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series B — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 40%.

Modeled valuation trajectory
$664.0M
Base estimate est.
$145.4M
Conservative case
$1.4B
Upside case
$266.7M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ca $40M–$100M round). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.

Series A · modeled $186.6M · 2020-03-112020Series C · modeled $664.0M · 2022-01-25Series C · modeled $657.5M · 2022-02-072022
Model inputs · modeled:benchmark-stage-stepup-v1
15%
Dilution assumption
Implied ownership sold in the financing.
73%
Survival probability
55% low · 85% high
1.32×/yr
Annual markup
1.51×/yr upside case
4.4 yr
Elapsed time used
4.4 yr actual, capped for stale marks
healthtech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
11 mo
Avg between rounds
$25.3M/yr
Capital velocity
6.3 yr
On record since
2020
First round
3
Rounds on file
How it compares to the market

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 11× above median
This company$48.3M
Sector median$4.5M
Latest round — vs other Series C rounds in sector (real $, this stage) 0.9× of median
This company$40.0M
Sector median$46.5M
Modeled value — vs sector median (estimate, all stages) 20× above median
This company$664.0M
Sector median$33.8M

Raised more than 90% of sector peers (real $). Modeled value above 95% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series C) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #13 of 39.

This companyCohort peer
$100.0M$1.0B$10.0B$10.0M$100.0M$1.0BCapital raised (log)Freedom Dental Funding, LLC · Series C Raised $100.0M · modeled $1.1B (est)Elevate Care International Topco LP · Series C Raised $98.4M · modeled $1.0B (est)Athelas Inc. · Series C Raised $54.4M · modeled $903.4M (est)Hazel Health, Inc. · Series C Raised $86.0M · modeled $817.6M (est)Health Gorilla, Inc. · Series C Raised $58.7M · modeled $816.3M (est)Employee Health Holdings, LP · Series C Raised $78.8M · modeled $779.7M (est)Magnolia Medical Technologies, Inc. · Series C Raised $94.2M · modeled $728.3M (est)Allied Health MSO Holdco, LLC · Series C Raised $62.8M · modeled $724.9M (est)Pearl Health, Inc. · Series C Raised $55.5M · modeled $721.8M (est)Veridian Healthcare Holdings LLC · Series C Raised $63.0M · modeled $692.5M (est)Accompany Health, Inc. · Series C Raised $56.3M · modeled $680.7M (est)Alleviant Medical, Inc. · Series C Raised $148.8M · modeled $677.4M (est)Reliance Health Inc. (this company) Raised $48.3M · modeled $664.0M (est)Reliance Health Inc.
CompanyStageRaised · realValue · estvs peer med.
Freedom Dental Funding, LLCSeries C$100.0M$1.1B2.33×
Elevate Care International Topco LPSeries C$98.4M$1.0B2.07×
Athelas Inc.Series C$54.4M$903.4M1.86×
Hazel Health, Inc.Series C$86.0M$817.6M1.68×
Health Gorilla, Inc.Series C$58.7M$816.3M1.68×
Employee Health Holdings, LPSeries C$78.8M$779.7M1.60×
Magnolia Medical Technologies, Inc.Series C$94.2M$728.3M1.50×
Allied Health MSO Holdco, LLCSeries C$62.8M$724.9M1.49×
Pearl Health, Inc.Series C$55.5M$721.8M1.48×
Veridian Healthcare Holdings LLCSeries C$63.0M$692.5M1.42×
Accompany Health, Inc.Series C$56.3M$680.7M1.40×
Alleviant Medical, Inc.Series C$148.8M$677.4M1.39×
Reliance Health Inc. this companySeries C$48.3M$664.0M1.37×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$8.3M2020-03-11$37.6M$186.6M90%
Series C$40.0M2022-01-25$266.7M$664.0M90%
Series C$40.0M2022-02-07$266.7M$657.5M45%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$8.3M2020-03-11
    • First recorded raise — entered as Series A.
    • 33 investors on this round.
  2. Series C$40.0M2022-01-25
    • Raised again after 23 mo — slower than the ~14 mo sector norm.
    • Round 4.8× larger than the prior — scaling up.
    • 9 investors on this round.
  3. Series C$40.0M2022-02-07
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
Intelligence
2023 ~Q1
Modeled next raise · ~11mo cadence
$40.0M
Modeled next size est.range $40.0M$64.0M
1.0×
Last step-up
$25.3M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Tidjane Deme2 other2020-03
Christian Braunfisch2022-01
Femi Kuti2020-03
Opeyemi Olumekun2020-03
Registry & provenance

Reliance Health Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
NG
Jurisdiction
1908845
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Ayr Wellness Inc.HealthtechSeries C$48.9M$457.5Msame sector · same stage
Quartet Health Holdings, Inc.HealthtechSeries C$51.4M$883.1Msame sector · same stage
Axial Healthcare Holdings, L.P.HealthtechSeries C$45.0M$408.6Msame sector · same stage
Equality Health, LLCHealthtechSeries C$45.0M$1.2Bsame sector · same stage
XO Health Inc.HealthtechSeries C$52.2M$323.7Msame sector · same stage
Linus Health, Inc.HealthtechSeries C$53.8M$859.9Msame sector · same stage
Evive Health, LLCHealthtechSeries C$43.0M$1.1Bsame sector · same stage
Athelas Inc.HealthtechSeries C$54.4M$903.4Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Eden Health, Inc.HealthtechSeries C$1.3B80%
Healthcare, Inc.HealthtechSeries D+$4.0B80%
Como Health Holdings, LLCHealthtechSeed$10.2M80%
Alternate Health Corp.HealthtechSeed$8.3M79%
Innovative Health LlcHealthtechSeries A$112.9M79%
Fuse Medical, Inc.HealthtechSeed$90.8M79%
Orient Health Inc.HealthtechSeries A$48.3M79%
Worldwide Innovative Healthcare Inc.HealthtechPre-Seed$9.5M79%
Frequently asked
How much funding has Reliance Health Inc. raised?
Reliance Health Inc. has raised approximately $48.3M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is Reliance Health Inc.'s estimated valuation?
Provath's modeled valuation for Reliance Health Inc. is approximately $664.0M (modeled range $145.4M–$1.4B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Reliance Health Inc. at?
Reliance Health Inc.'s latest modeled financing stage is Series C. Its most recent recorded round closed around Tue Jan 25.
What does Reliance Health Inc. do and where is it based?
Reliance Health Inc. operates in the Healthtech sector, based in AUSTIN, LA, Nigeria; Austin, TX, USA. We make healthcare in emerging markets affordable and accessible
Explore related

See where Reliance Health Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Reliance Health Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.